0001179110-14-009846.txt : 20140624
0001179110-14-009846.hdr.sgml : 20140624
20140605170328
ACCESSION NUMBER: 0001179110-14-009846
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140604
FILED AS OF DATE: 20140605
DATE AS OF CHANGE: 20140605
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Celldex Therapeutics, Inc.
CENTRAL INDEX KEY: 0000744218
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 133191702
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 119 FOURTH AVE
CITY: NEEDHAM
STATE: MA
ZIP: 02494
BUSINESS PHONE: 7814330771
MAIL ADDRESS:
STREET 1: 119 FOURTH AVE
CITY: NEEDHAM
STATE: MA
ZIP: 02494-2725
FORMER COMPANY:
FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19980828
FORMER COMPANY:
FORMER CONFORMED NAME: T CELL SCIENCES INC
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Elston George
CENTRAL INDEX KEY: 0001429932
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-15006
FILM NUMBER: 14894305
MAIL ADDRESS:
STREET 1: 124 CHATHAM STREET
CITY: CHATHAM
STATE: NJ
ZIP: 07928
4
1
edgar.xml
FORM 4 -
X0306
4
2014-06-04
0
0000744218
Celldex Therapeutics, Inc.
CLDX
0001429932
Elston George
C/O CELLDEX THERAPEUTICS, INC.
53 FRONTAGE ROAD
HAMPTON
NJ
08827
1
0
0
0
Common Stock
2014-06-04
4
A
0
2000
A
12000
D
Non-Qualified Stock Option (right to buy)
13.45
2014-06-04
4
A
0
2000
0
A
2024-06-04
Common Stock
2000
2000
D
On June 4, 2014, the Company awarded 2,000 shares of the Company common stock as an annual equity grant in the form of restricted stock awards under the Celldex Therapeutics, Inc. 2008 Stock Option and Incentive Plan, subject to time-based forfeiture restrictions.
Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan.
Such option vests in four equal quarterly installments beginning September 4, 2014.
/s/ Avery W. Catlin, attorney in fact for George Elston
2014-06-05